YPR170C Antibody

What is YPR170C and why is it important in yeast research?

YPR170C is a protein encoded by the YPR170C gene in Saccharomyces cerevisiae (strain ATCC 204508/S288c), commonly known as Baker's yeast. This protein has significant research value as it represents a model system for studying fundamental eukaryotic cellular processes. Antibodies targeting YPR170C enable researchers to investigate protein expression, localization, and function within yeast cells. The protein is part of the extensive proteome of S. cerevisiae, which serves as an important model organism for understanding basic eukaryotic cell biology, including protein-protein interactions and metabolic pathways .

What are the validated applications for YPR170C antibody?

YPR170C antibody has been validated for several key research applications:

• Enzyme-Linked Immunosorbent Assay (ELISA): The antibody can be used at dilutions between 1/500 and 1/2500 for detecting the target protein in ELISA-based assays .

• Western Blotting (WB): The antibody is effective at dilutions ranging from 1/100 to 1/500 for Western blot analysis. In Western blot applications, the antibody typically identifies the target protein through chemiluminescence detection methods .

These applications allow researchers to both quantify YPR170C protein levels and analyze its expression patterns in various experimental conditions.

How does the polyclonal nature of YPR170C antibody affect experimental design?

The polyclonal nature of YPR170C antibody has significant implications for experimental design and interpretation:

Polyclonal antibodies like the YPR170C antibody contain a heterogeneous mixture of immunoglobulins that recognize multiple epitopes on the target antigen. This characteristic provides several experimental advantages including enhanced sensitivity through binding to multiple epitopes on each target molecule, which amplifies signal detection. Additionally, this makes the antibody more robust against minor protein modifications or conformational changes that might render a single epitope unrecognizable .

How can YPR170C antibody be used in protein-protein interaction studies?

YPR170C antibody can be instrumental in protein-protein interaction studies through several methodological approaches:

• Co-immunoprecipitation (Co-IP): Researchers can use the YPR170C antibody to pull down the target protein along with its interacting partners. The polyclonal nature of the antibody is advantageous here, as it can recognize multiple epitopes, potentially allowing for more efficient immunoprecipitation without disrupting protein-protein interactions.

• Proximity-based labeling: When coupled with techniques like BioID or APEX, the antibody can help validate proximity-based labeling results by confirming the presence of YPR170C in protein complexes.

• Protein fragment complementation assays: As noted in reference literature, antibodies can be used to validate results from "protein-fragment complementation assays for studying and dissecting large-scale and dynamic protein-protein interactions in living cells" .

The antibody's IgG isotype and purification by antigen affinity chromatography make it suitable for these advanced applications, though researchers should optimize conditions for each specific experimental setup .

What considerations are important when using YPR170C antibody in microscopy-based localization studies?

When employing YPR170C antibody for subcellular localization studies using microscopy techniques, researchers should consider several critical factors:

• Fixation and permeabilization methods: Different protocols may affect epitope accessibility. While the antibody recognizes the native antigen, fixation can alter protein structure. Testing multiple fixation methods (paraformaldehyde, methanol, or glutaraldehyde) is advisable to determine optimal conditions.

• Secondary antibody selection: Since the YPR170C antibody is raised in rabbit, researchers must select appropriate species-specific secondary antibodies. For multiplexing with other primary antibodies, consider species compatibility to avoid cross-reactivity .

• Controls for specificity: Include both positive controls (known expression patterns) and negative controls (blocking peptide competition or samples lacking the target protein) to validate staining patterns.

• Subcellular localization prediction: According to GO terms associated with similar yeast proteins, researchers should consider both nuclear (GO:0005634) and cytoplasmic (GO:0005737) localizations when interpreting results .

How might rigidity and conformational dynamics affect YPR170C antibody binding efficacy?

Recent research on antibody structure and function highlights how conformational dynamics can significantly impact antibody-antigen interactions:

Studies have demonstrated that antibody evolution involves progressive rigidification of the molecule structure. As described in the literature, "rigidity emerges during antibody evolution" through a process where germline antibodies typically display greater conformational flexibility compared to their affinity-matured counterparts .

For YPR170C antibody applications, this has several implications:

• Binding kinetics: The conformational flexibility could influence both association and dissociation rates in antibody-antigen interactions. Researchers may observe differences in binding stability under varying experimental conditions.

• Temperature sensitivity: As observed in Distance Constraint Model (DCM) studies, antibodies exhibit characteristic melting temperatures (Tm) and may display different binding characteristics at various temperatures. The YPR170C antibody should be used within its optimal temperature range, typically room temperature for most applications, avoiding conditions that could denature its structure .

• Buffer considerations: The stability and binding efficacy of the antibody are dependent on buffer conditions. The YPR170C antibody is supplied in phosphate-buffered saline with 50% glycerol and 0.03% Proclin 300 as preservatives, which should be considered when designing experimental protocols .

What are the optimal storage and handling conditions for maintaining YPR170C antibody activity?

Proper storage and handling of YPR170C antibody are critical for maintaining its functionality over time:

• Storage temperature: Upon receipt, the antibody should be stored at -20°C or -80°C to maintain its activity. Long-term storage at -80°C is generally recommended for maximum stability .

• Aliquoting: To prevent repeated freeze-thaw cycles, which can denature the antibody, researchers should divide the stock solution into small single-use aliquots before freezing.

• Freeze-thaw considerations: As explicitly stated in the product information, "Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended" .

• Working dilution preparation: When preparing working dilutions, use fresh buffers free of contaminants. For optimal results, diluted antibody solutions should be prepared just prior to use rather than stored for extended periods.

• Buffer compatibility: The antibody is provided in phosphate-buffered saline (PBS) with 50% glycerol and 0.03% Proclin 300 as preservatives. These components should be considered when designing experiments to ensure they don't interfere with downstream applications .

What strategies can resolve inconsistent results in Western blotting with YPR170C antibody?

When facing variable or inconsistent results with YPR170C antibody in Western blotting applications, consider the following optimization strategies:

• Sample preparation optimization:

  • Ensure complete protein denaturation with appropriate SDS and heat treatment

  • Use fresh protease inhibitors to prevent target degradation

  • Optimize protein loading amount (typically 10-50 μg of total protein per lane)

• Antibody dilution optimization:

  • Test multiple dilutions within the recommended range (1/100 to 1/500)

  • Prepare fresh antibody dilutions for each experiment

  • Consider extended incubation times (overnight at 4°C) for weaker signals

• Detection system considerations:

  • For ECL detection systems, ensure reagents are fresh and properly mixed

  • Consider using enhanced sensitivity substrates for low-abundance targets

  • Optimize exposure times (multiple exposures may be necessary)

• Expected banding pattern:

  • Based on similar antibodies, expect distinct bands with appropriate molecular weights

  • In Western blot applications, multiple bands might appear (similar antibodies have shown bands at 13kD and 17kD), which may represent different isoforms or post-translational modifications

• Blocking optimization:

  • Test different blocking agents (BSA vs. non-fat dry milk)

  • Optimize blocking time and temperature

How can researchers validate YPR170C antibody specificity in their experimental system?

Validating antibody specificity is crucial for ensuring reliable experimental results. For YPR170C antibody, consider these validation approaches:

• Genetic controls:

  • Use YPR170C knockout or knockdown yeast strains as negative controls

  • Employ YPR170C overexpression systems as positive controls to confirm signal proportionality

• Peptide competition assays:

  • Pre-incubate the antibody with excess purified YPR170C protein or immunogenic peptide

  • A specific antibody will show significantly reduced signal when pre-absorbed

• Orthogonal detection methods:

  • Compare antibody-based detection with orthogonal methods such as mass spectrometry

  • Validate findings with a second antibody targeting a different epitope on YPR170C

• Cross-reactivity assessment:

  • Test the antibody against related yeast proteins to evaluate potential cross-reactivity

  • Perform Western blotting with recombinant proteins of known concentration to assess sensitivity and specificity

• Application-specific validation:

  • For immunoprecipitation applications, analyze pull-down efficiency by comparing input, bound, and unbound fractions

  • For immunohistochemistry or immunofluorescence, include peptide competition controls alongside primary antibody omission controls

How does the performance of polyclonal YPR170C antibody compare with potential monoclonal alternatives?

Understanding the comparative advantages and limitations of polyclonal versus monoclonal antibodies is important for experimental design with YPR170C:

Performance Comparison Table:

The polyclonal YPR170C antibody offers advantages in signal strength and robustness to protein modifications, making it particularly useful for detection of native proteins in complex samples. The recognition of multiple epitopes provides a higher probability of detection even if some epitopes are masked or modified .

For critical quantitative experiments requiring absolute specificity and reproducibility, researchers might consider using both polyclonal and monoclonal antibodies in parallel when available.

What insights from autoantibody research might apply to optimizing YPR170C antibody applications?

Recent research on autoantibodies provides valuable insights that can be applied to optimize YPR170C antibody applications:

Studies on autoantibodies against cold-shock-protein YB-1 in cancer patients have revealed important considerations about antibody-antigen interactions. This research demonstrates that autoantibodies can target specific domains of proteins and affect the protein's half-life. Similarly, researchers using YPR170C antibody should consider:

• Epitope accessibility in different experimental conditions: Just as autoantibodies target specific protein domains, the accessibility of YPR170C epitopes may vary depending on experimental conditions. Optimization of sample preparation protocols may be necessary to expose relevant epitopes .

• Antibody-induced stabilization effects: Research has shown that "cancer sera containing autoantibodies that target YB-1 extend the half-life of the YB-1 protein." Similarly, the binding of YPR170C antibody might influence the stability of its target protein, potentially affecting experimental outcomes, particularly in assays measuring protein turnover or stability .

• Conformational epitopes: Autoantibody research highlights the importance of both linear and conformational epitopes. When using YPR170C antibody for applications like immunoprecipitation, native conditions might preserve important conformational epitopes, while denaturing conditions in Western blotting might expose different linear epitopes .

How can advanced computational modeling enhance experimental design with YPR170C antibody?

Advanced computational approaches can significantly enhance experimental design and interpretation when working with YPR170C antibody:

• Epitope prediction and antibody binding simulation:

  • Computational Distance Constraint Models (DCM) can predict antibody rigidity and flexibility

  • Molecular dynamics simulations can predict conformational changes that may affect epitope accessibility

  • These approaches can help optimize antibody dilutions and incubation conditions based on predicted binding kinetics

• Cross-reactivity prediction:

  • Sequence alignment tools can identify proteins with similar epitopes to YPR170C

  • Structural homology modeling can predict potential cross-reactive proteins

  • This information can guide the design of appropriate controls and validation experiments

• Optimal condition prediction:

  • Computational modeling of thermal stability (using parameters like those described in the literature: u, v, nat, δ) can predict optimal temperature ranges for antibody applications

  • Models can estimate the impact of buffer conditions on antibody performance

• Antibody-antigen interaction analysis:

  • Z-score analysis techniques (as described in the literature) can be used to quantify changes in backbone flexibility

  • Researchers can apply computational approaches to understand "both local and non-local changes in rigidity or flexibility" that might affect antibody binding

How might YPR170C antibody contribute to yeast protein-protein interaction network mapping?

YPR170C antibody holds significant potential for comprehensive mapping of yeast protein interaction networks:

Contemporary research techniques emphasize the importance of understanding protein interactions in their native cellular environment. As noted in related literature, "a toolkit of protein-fragment complementation assays for studying and dissecting large-scale and dynamic protein-protein interactions in living cells" represents one approach to this challenge .

YPR170C antibody could contribute to this research direction through:

• Validation of high-throughput interaction datasets: The antibody can confirm interactions identified through techniques like yeast two-hybrid or mass spectrometry by co-immunoprecipitation followed by Western blotting.

• Temporal dynamics studies: Using the antibody in time-course experiments could reveal how YPR170C interactions change during different cellular processes or stress responses.

• Subcellular interaction mapping: Combined with fractionation techniques, the antibody could help determine where within the cell specific protein-protein interactions occur, providing spatial context to interaction data.

• Cross-linking immunoprecipitation (CLIP) approaches: The antibody could be employed in protocols that capture transient or weak interactions through chemical cross-linking prior to immunoprecipitation.

What emerging antibody engineering principles might improve next-generation YPR170C antibodies?

Recent advances in antibody engineering suggest several approaches that could enhance next-generation YPR170C antibodies:

Recent research on antibodies against SARS-CoV-2 has demonstrated the value of innovative antibody engineering approaches. Scientists have discovered "a method to use two antibodies, one to serve as a type of anchor by attaching to an area of the virus that does not change very much and another to inhibit the virus's ability to infect cells" .

Similar principles could be applied to create improved YPR170C antibodies:

• Bispecific antibody development: Engineering antibodies that simultaneously target YPR170C and a common tag or fusion protein could enhance specificity and versatility.

• Antibody fragment optimization: Creating Fab or scFv fragments that retain specificity while offering better tissue penetration for certain applications.

• Affinity maturation techniques: Using directed evolution or computational design to enhance binding affinity without compromising specificity.

• Strategic epitope targeting: Designing antibodies against highly conserved regions of YPR170C to ensure consistent recognition across different experimental conditions.

• Site-specific conjugation: Developing antibodies with precisely positioned conjugation sites for fluorophores or enzymes to minimize impact on antigen binding.

How can YPR170C antibody applications be integrated with emerging 'omics technologies?

Integration of YPR170C antibody applications with cutting-edge 'omics technologies offers exciting research possibilities:

• Antibody-based proteomics integration:

  • YPR170C antibody can be used for immunoprecipitation followed by mass spectrometry (IP-MS) to identify protein complexes

  • The antibody could serve in proximity labeling approaches like BioID or APEX to map local protein neighborhoods

  • These applications would complement large-scale proteomics data by providing validation and spatial context

• Integration with transcriptomics:

  • Correlating YPR170C protein levels (detected by the antibody) with transcript levels could reveal post-transcriptional regulation mechanisms

  • ChIP-seq applications using YPR170C antibody could identify genomic binding sites if the protein has DNA-binding properties

• Single-cell applications:

  • Adapting YPR170C antibody for single-cell proteomics through techniques like CyTOF or CODEX

  • These approaches would allow researchers to examine cell-to-cell variability in YPR170C expression and localization

• Structural biology integration:

  • Using the antibody to isolate native protein complexes for cryo-EM structural analysis

  • The antibody itself could be used to facilitate crystallization of difficult target proteins through co-crystallization approaches

By combining these approaches, researchers can develop a multi-dimensional understanding of YPR170C biology that integrates information across genomic, transcriptomic, proteomic, and structural levels.